Spectral Molecular Imaging, Inc. to Develop a New Generation of Multispectral Imaging Endoscopes Based on Optical Technology from Omega Optical

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Cascade Technologies, Inc., (OTCBB: CSDT) announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.